Filing Flows › Milestone Scientific (MLSS) › Q2 2026
Milestone Scientific (MLSS) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 13, 2026
Milestone Scientific (MLSS) reported revenue of $2.8M for the second quarter 2026 (Q2 2026), +22% from a year earlier and +31% from the quarter before. Operating margin was -37.4%, net loss $1.1M (37.3% of revenue).
Milestone Scientific, Q2 2026: revenue $2.8M (+22% year over year), operating margin -37.4%, net loss $1.1M, operating cash flow −$585K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | +31% | +22% |
| Operating profit | −$1.1M | — | — |
| Net earnings | −$1.1M | — | — |
| Operating cash flow | −$585K | -774% | — |
What changed
Revenue was $2.8M in Q2 2026, up 22% year over year and up 31% from the previous quarter.
Gross margin was 67.2%, down 2.4 points from Q2 2025. Operating costs exceeded revenue by $1.1M, an operating margin of -37.4%. Operating expenses fell 4% while revenue rose 22%. The quarter ended with a net loss of $1.1M, wider than the previous quarter's $840K loss.
Operating cash flow was −$585K. Non-cash charges added back $20K of depreciation and amortization and $310K of share-based compensation. Working capital and other items added $145K. Capital expenditures of $4K exceeded it, leaving free cash flow of −$589K.
Questions
What was Milestone Scientific's revenue in the second quarter 2026?
Milestone Scientific (MLSS) reported revenue of $2.8M for the second quarter 2026 (Q2 2026), +22% from a year earlier and +31% from the quarter before.
Was Milestone Scientific profitable in the second quarter 2026?
Operating loss was $1.1M (-37.4% of revenue) and net loss $1.1M.